진단용 방사선 동위 원소 시장 : 라디오 아이소토프별, 용도별, 이미징 모달리티별, 질환 적응증별, 최종 사용자별, 지역별

Global diagnostic radioisotopes market size is expected to reach US$ 10.36 Bn by 2030, from US$ 5.67 Bn in 2023, at a CAGR of 9% during the forecast period

Figure 1. Global Diagnostic Radioisotopes Market Share (%), By Region, 2023

Global diagnostic radioisotopes market is witnessing significant growth due to increasing prevalence of chronic diseases, advancements in medical imaging technology, and rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

Global diagnostic radioisotopes market are influenced by several factors. Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders boosts demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. The limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. Increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to boost demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable its use for the selection of patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.

Key features of the study:

• This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Cardinal Health, Lantheus Holdings, Inc., Bayer AG, Bracco, Eckert & Ziegler, Nordion (Canada) Inc., NTP Radioisotopes, Curium, Jubilant Life Sciences Ltd, IRE, Isotopia Molecular Imaging Ltd., Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., Sumitomo Heavy Industries, Ltd., and Telix Pharmaceuticals Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

• By Radioisotope
  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others
• By Application
  • Diagnostic Application
  • Therapeutic Application
• By Imaging Modality
• • SPECT
  • PET
  • Beta Emitters
• By End User
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others
• By Indication
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Orthopedic
  • Endocrinology
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top companies in Global Diagnostic Radioisotopes Market
  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Cardinal Health
  • Lantheus Holdings, Inc.
  • Bayer AG
  • Bracco
  • Eckert & Ziegler
  • Nordion (Canada) Inc.
  • NTP Radioisotopes
  • Curium
  • Jubilant Life Sciences Ltd
  • IRE
  • Isotopia Molecular Imaging Ltd.
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Telix Pharmaceuticals Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Diagnostic Radioisotopes, By Radioisotope
  • Market Diagnostic Radioisotopes, By Application
  • Market Diagnostic Radioisotopes, By Imaging Modality
  • Market Diagnostic Radioisotopes, By Indication
  • Market Diagnostic Radioisotopes, By End User
  • Market Diagnostic Radioisotopes, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
  • Restraints
• High cost of diagnostic radioisotopes
  • Opportunities
• Increasing adoption of hybrid imaging techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Technetium-99m
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Thallium-201
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Gallium-67
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Iodine-123
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• FDG
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Rubidium-82
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Diagnostic Radioisotopes Market, By Application, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Diagnostic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Therapeutic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• SPECT
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• PET
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Beta Emitters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Diagnostic Radioisotopes Market, By Indication, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Thyroid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Diagnostic Radioisotopes Market, By End User, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Diagnostic Radioisotopes Market, By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,( US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

11. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
• Koninklijke Philips N.V.
• Cardinal Health
• Lantheus Holdings, Inc.
• Bayer AG
• Bracco
• Eckert & Ziegler
• Nordion (Canada) Inc.
• NTP Radioisotopes
• Curium
• Jubilant Life Sciences Ltd
• IRE
• Isotopia Molecular Imaging Ltd.
• Mallinckrodt Nuclear Medicine LLC
• Jubilant DraxImage Inc.
• Sumitomo Heavy Industries, Ltd.
• Telix Pharmaceuticals Limited
• Analyst Views

12. Section

• Research Methodology
• About us